ENGN Logo

enGene Holdings Inc. Common Stock (ENGN) 

NASDAQ$4.51-0.42 (-8.52%)
Market Cap
$251.32M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
53 of 919
Rank in Industry
39 of 523

ENGN Insider Trading Activity

ENGN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$7,920,35810100
Sells
$000

Related Transactions

Forbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner9$7.86M0$0$7.86M
Cooper Ronald Harold WilfredChief Executive Officer1$57,0000$0$57,000

About enGene Holdings Inc. Common Stock

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

Insider Activity of enGene Holdings Inc. Common Stock

Over the last 12 months, insiders at enGene Holdings Inc. Common Stock have bought $7.92M and sold $0 worth of enGene Holdings Inc. Common Stock stock.

On average, over the past 5 years, insiders at enGene Holdings Inc. Common Stock have bought $4.03M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Forbion Growth Opportunities Fund I Cooperatief U.A. (10 percent owner) — $7.86M. Cooper Ronald Harold Wilfred (Chief Executive Officer) — $57,000.

The last purchase of 561,797 shares for transaction amount of $5M was made by Forbion Growth Opportunities Fund I Cooperatief U.A. (10 percent owner) on 2024‑10‑30.

List of Insider Buy and Sell Transactions, enGene Holdings Inc. Common Stock

2024-10-30PurchaseForbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
561,797
1.1339%
$8.90$5M-21.95%
2024-10-08PurchaseForbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
800
0.0012%
$6.60$5,278-0.92%
2024-10-07PurchaseForbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
11,844
0.0176%
$6.55$77,531+5.53%
2024-10-04PurchaseForbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
5,997
0.0089%
$6.54$39,242+6.11%
2024-10-03PurchaseForbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
5,769
0.0085%
$6.48$37,397+7.85%
2024-10-02PurchaseForbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
10,153
0.0147%
$6.37$64,697+8.20%
2024-10-01PurchaseForbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
35,279
0.0515%
$6.44$227,158+7.07%
2024-09-30PurchaseForbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
341,332
0.4906%
$6.34$2.16M+5.45%
2024-09-27PurchaseForbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
41,639
0.0564%
$5.97$248,699+14.88%
2024-09-27PurchaseCooper Ronald Harold WilfredChief Executive Officer
10,000
0.0129%
$5.70$57,000+14.88%
2023-12-29PurchaseForbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
10,020
0.0206%
$9.06$90,771-6.28%
2023-12-28PurchaseForbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
5,050
0.0088%
$7.69$38,827+6.66%
2023-12-27PurchaseForbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
2,750
0.0045%
$7.17$19,711+17.85%
Total: 13
*Gray background shows transactions not older than one year

Insider Historical Profitability

6.07%
Forbion Growth Opportunities Fund I Cooperatief U.A.10 percent owner
3032430
5.9486%
$14.95M120+6.07%
Cooper Ronald Harold WilfredChief Executive Officer
10000
0.0196%
$49,300.0010
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$99,438,720
81
6.74%
$252.53M
$69,130,029
69
25.63%
$248.44M
$17,983,739
41
102.87%
$252.79M
$2,545,071
34
16.59%
$243.54M
$18,554,304
31
-11.72%
$241.31M
$41,069,367
23
54.64%
$230.16M
$3,513,995
18
-13.04%
$217.35M
$2,081,205
17
-20.90%
$235.6M
$46,787,419
16
-16.42%
$260.54M
$58,962,528
9
37.89%
$270.98M
$157,484,277
8
28.67%
$248.84M
$14,995,689
8
3.76%
$280.5M
$94,000,000
7
-20.84%
$255.76M
$335,001
6
-23.71%
$258.23M
$13,419,689
6
-19.79%
$258.88M
$12,010,220
4
-72.15%
$229.33M
enGene Holdings Inc. Common Stock
(ENGN)
$149,309
3
6.07%
$251.32M
$4,888,000
3
-20.50%
$220.78M
$102,796
1
-21.40%
$273.68M

ENGN Institutional Investors: Active Positions

Increased Positions24+70.59%13M+37.86%
Decreased Positions14-41.18%5M-15.4%
New Positions14New3MNew
Sold Out Positions6Sold Out3MSold Out
Total Postitions44+29.41%42M+22.46%

ENGN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Fcpm Iii Services B.V.$47,778.0018.89%9.63M+954,610+11%2024-12-31
Vr Adviser, Llc$25,030.009.9%5.05M+1M+41.52%2024-12-31
Kynam Capital Management, Lp$24,771.009.79%4.99M+3M+187.64%2024-12-31
Deep Track Capital, Lp$22,606.008.94%4.56M+2M+74.78%2024-12-31
Blue Owl Capital Holdings Lp$15,673.006.2%3.16M+101,006+3.3%2024-12-31
Cormorant Asset Management, Lp$11,525.004.56%2.32M+1M+132.36%2024-12-31
Bvf Inc/Il$10,446.004.13%2.11M-145,000-6.44%2024-12-31
Adage Capital Partners Gp, L.L.C.$7,588.003%1.53M-800,000-34.34%2024-12-31
Point72 Asset Management, L.P.$6,075.002.4%1.22M+561,797+84.74%2024-12-31
Franklin Resources Inc$5,902.002.33%1.19M00%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.